Scarica l'app Stockscreener
189.90
0.30%
-0.57
Dopo l'orario di chiusura:
189.90
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DHR Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$190.47
Aprire:
$190
Volume 24 ore:
6.51M
Relative Volume:
1.61
Capitalizzazione di mercato:
$135.91B
Reddito:
$23.82B
Utile/perdita netta:
$3.77B
Rapporto P/E:
36.87
EPS:
5.15
Flusso di cassa netto:
$4.90B
1 W Prestazione:
+2.90%
1M Prestazione:
-4.54%
6M Prestazione:
-20.77%
1 anno Prestazione:
-24.86%
Intervallo 1D:
$187.78
$190.99
Intervallo di 1 settimana:
$186.99
$192.49
Portata 52W:
$171.00
$281.70
Danaher Corp Stock (DHR) Company Profile
Nome
Danaher Corp
Settore
Industria
Telefono
(202) 828-0850
Indirizzo
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Confronta DHR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
189.90 | 132.07B | 23.82B | 3.77B | 4.90B | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
402.82 | 148.60B | 42.90B | 6.52B | 6.72B | 17.05 |
|
IDXX
Idexx Laboratories Inc
|
513.36 | 40.34B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
111.92 | 30.82B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
140.33 | 23.70B | 15.50B | 1.33B | 2.16B | 7.34 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-03-14 | Aggiornamento | Stifel | Hold → Buy |
| 2025-02-03 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2024-12-13 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-31 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Iniziato | HSBC Securities | Hold |
| 2023-12-13 | Ripresa | Wolfe Research | Peer Perform |
| 2023-12-07 | Downgrade | Goldman | Buy → Neutral |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-05-01 | Iniziato | SVB Securities | Outperform |
| 2023-04-26 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-04-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-10-24 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-08-17 | Ripresa | Bernstein | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-06-01 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Iniziato | Bernstein | Outperform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-10 | Reiterato | BofA Securities | Buy |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-23 | Reiterato | Goldman | Buy |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-04-07 | Ripresa | Robert W. Baird | Outperform |
| 2021-03-03 | Ripresa | Barclays | Overweight |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Ripresa | Stifel | Hold |
| 2019-10-28 | Reiterato | Needham | Buy |
| 2019-10-14 | Ripresa | Credit Suisse | Outperform |
| 2019-07-19 | Reiterato | Needham | Buy |
| 2019-06-11 | Iniziato | Piper Jaffray | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-04-17 | Reiterato | Needham | Buy |
| 2019-02-28 | Reiterato | Needham | Buy |
| 2019-02-25 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-03 | Iniziato | Needham | Buy |
| 2018-04-20 | Reiterato | Stifel | Buy |
Mostra tutto
Danaher Corp Borsa (DHR) Ultime notizie
Danaher (NYSE:DHR) Partners With AstraZeneca To Advance Precision Medicine Diagnostics - Yahoo
Danaher Partners With AstraZeneca to Support Precision Medicine - TradingView
Boston Common Asset Management LLC Boosts Position in Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Co. (NYSE:DHR) Stock Holdings Decreased by Neville Rodie & Shaw Inc. - MarketBeat
3,587 Shares in Danaher Co. (NYSE:DHR) Acquired by Fire Capital Management LLC - MarketBeat
MassMutual Private Wealth & Trust FSB Buys 8,293 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Centaurus Financial Inc. Purchases 4,276 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Siemens Fonds Invest GmbH Has $1.17 Million Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
Mackenzie Financial Corp Grows Stock Position in Danaher Co. (NYSE:DHR) - MarketBeat
Is Danaher Stock Outperforming the Nasdaq? - MSN
Vise Technologies Inc. Boosts Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Corporation (DHR) Launches Partnership with AstraZeneca PLC (AZN) to Scale Next-Gen Precision Medicine Tests - Insider Monkey
Danaher (NYSE:DHR) Rating Lowered to Hold at Wall Street Zen - MarketBeat
Danaher (DHR) Partners with AstraZeneca for Precision Medicine Tools - GuruFocus
Danaher partners with AstraZeneca on AI diagnostics - Investing.com
Danaher partners with AstraZeneca on AI diagnostics By Investing.com - Investing.com India
Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine - Yahoo Finance
Is Danaher Stock Outperforming The Nasdaq? - Barchart.com
Chancellor Financial Group WB LP Takes Position in Danaher Co. (NYSE:DHR) - MarketBeat
3,492 Shares in Danaher Co. (NYSE:DHR) Acquired by DSG Capital Advisors LLC - MarketBeat
111 Capital Purchases Shares of 7,555 Danaher Co. (NYSE:DHR) - MarketBeat
Thoma Capital Management LLC Acquires New Shares in Danaher Co. (NYSE:DHR) - MarketBeat
PKO Investment Management Joint Stock Co Makes New $2.41 Million Investment in Danaher Co. (NYSE:DHR) - MarketBeat
Voloridge Investment Management LLC Takes Position in Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Co. (NYSE:DHR) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Parr Mcknight Wealth Management Group LLC Takes $1.68 Million Position in Danaher Co. (NYSE:DHR) - MarketBeat
$100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today - Benzinga
TFR Capital LLC. Acquires Shares of 5,349 Danaher Co. (NYSE:DHR) - MarketBeat
Employees Retirement System of Texas Invests $55.16 Million in Danaher Co. (NYSE:DHR) - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Acquires New Position in Danaher Co. (NYSE:DHR) - MarketBeat
B. Riley Wealth Advisors Inc. Sells 2,651 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Nuclera and Danaher-owned US ally boost protein proposition - Business Weekly
Focus Partners Advisor Solutions LLC Acquires 4,958 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Gordian Capital Singapore Pte Ltd Has $1.61 Million Stock Position in Danaher Co. (NYSE:DHR) - MarketBeat
Worldquant Millennium Advisors LLC Purchases New Stake in Danaher Co. (NYSE:DHR) - MarketBeat
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Boosts Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
Cypress Asset Management Inc. TX Purchases New Shares in Danaher Co. (NYSE:DHR) - MarketBeat
Putney Financial Group LLC Makes New $866,000 Investment in Danaher Co. (NYSE:DHR) - MarketBeat
RedJay Asset Management Inc. Makes New $5.74 Million Investment in Danaher Co. (NYSE:DHR) - MarketBeat
Danaher’s SWOT analysis: biotech recovery, cost savings boost stock outlook - Investing.com
GF Fund Management CO. LTD. Makes New Investment in Danaher Co. (NYSE:DHR) - MarketBeat
GTS Securities LLC Trims Stock Position in Danaher Co. (NYSE:DHR) - MarketBeat
Adalta Capital Management LLC Lowers Stock Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
Cell-Free DNA Isolation and Extraction Market - GlobeNewswire Inc.
Forum Financial Management LP Has $1.88 Million Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
Warm Springs Advisors Inc. Takes $438,000 Position in Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Co. (NYSE:DHR) Shares Bought by North Star Asset Management Inc. - MarketBeat
Williams Jones Wealth Management LLC. Trims Stock Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
Here's Why Investors Should Consider Retaining Danaher Stock Now - MSN
Public Employees Retirement System of Ohio Sells 14,088 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Sone Capital Management LLC Buys Shares of 50,636 Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Corp Azioni (DHR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):